Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference
April 26 2023 - 4:05PM
Business Wire
Paragon 28, Inc. (NYSE: FNA), a leading medical device company
exclusively focused on the foot and ankle orthopedic market, today
announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch,
CFO, will participate in a fireside chat at the Bank of America
Securities 2023 Healthcare Conference on Wednesday, May 10, 2023,
at 5:20 p.m. Eastern Time / 3:20 p.m. Mountain Time.
A live webcast, as well as the archived recording, will be
available on the investor relations section of the Company’s
website at ir.paragon28.com.
About Paragon 28, Inc.
Based in Englewood, Colo., Paragon 28 is a leading medical
device company exclusively focused on the foot and ankle orthopedic
market and is dedicated to improving patient lives. From the onset,
Paragon 28® has provided innovative orthopedic solutions,
procedural approaches and instrumentation that cover a wide range
of foot and ankle ailments including fracture fixation, forefoot,
ankle, progressive collapsing foot deformity (PCFD) or flatfoot,
charcot foot and orthobiologics. The company designs products with
both the patient and surgeon in mind, with the goal of improving
outcomes, reducing ailment recurrence and complication rates, and
making the procedures simpler, consistent, and reproducible.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230426005009/en/
Investor Contact: Matt Brinckman Senior Vice President,
Strategy and Investor Relations (720) 912-1332
mbrinckman@paragon28.com
Paragon 28 (NYSE:FNA)
Historical Stock Chart
From Jul 2024 to Aug 2024
Paragon 28 (NYSE:FNA)
Historical Stock Chart
From Aug 2023 to Aug 2024